trial · primary record
Biopsy Procedure
Metastatic Pancreatic Ductal Adenocarcinoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 43 |
| Primary completion | 2027-04-30 |
| Primary endpoint | Dose limiting toxicity rate |
| Registry ID | NCT05685602 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:30.899Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05685602
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biopsy Procedure · compound